作者: Edoardo Villani , Luca Marelli , Andrea Dellavalle , Massimiliano Serafino , Paolo Nucci
DOI: 10.1016/J.JTOS.2020.09.001
关键词:
摘要: Meibomian gland dysfunction (MGD) can be considered the leading cause of dry eye disease (DED) and one most common ophthalmic disorders found in clinical practice. The growing body literature provides a substantial amount information on this condition, but more efforts are needed to better interpret research data properly apply them daily practice., In article, we reviewed recent publications MGD diagnosis management, focusing highest available level evidence, provided by well-designed well-reported studies humans., Latest evidences mainly focused imaging techniques, including meibography, optical coherence tomography (OCT), vivo confocal microscopy. Meibographic parameters, such as drop-out glands' distortion, show great diagnostic accuracy, which accounts for their widespread use practice research., Recent randomized controlled trials treatment role antibiotics, steroids, essential fatty acids, intraductal meibomian probing, electronic heating devices intense pulsed light therapy.